To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene BAG3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
451 supporting clones for gene BAG3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
Z19408 leg muscle, skeletal muscle .c-u 943 to 1264 1 to 326       326/337
(96 %)
6 diff
(98.3 %id)
N44345   .c-u 1056 to 1312 1 to 257       257/257
(100 %)
0 diff
(100 %id)
Z24890 leg muscle, skeletal muscle .b 772 to 953 1 to 182       182/337
(54 %)
2 diff
(99.5 %id)
AA312671   .b 633 to 1131 1 to 499       499/499
(100 %)
0 diff
(100 %id)
AA318757 Spleen .c-u 1079 to 1298 1 to 222       222/222
(100 %)
2 diff
(99.1 %id)
AA319013 adrenal gland .c-u 684 to 1009 1 to 326       326/326
(100 %)
1 diff
(99.7 %id)
AA320713 adipose tissue, white .a 1554 to 1935 1 to 381       381/381
(100 %)
5 diff
(98.7 %id)
AA350776 brain .a 1674 to 2075 399 to 1       399/399
(100 %)
1 diff
(99.8 %id)
AA362082 breast .c-u 616 to 880 1 to 265       265/266
(99 %)
4 diff
(98.5 %id)
AA377379 small intestine .c-u 751 to 1023 1 to 273       273/275
(99 %)
2 diff
(99.3 %id)
AA383048 testis .c-u 757 to 925 1 to 169       169/169
(100 %)
0 diff
(100 %id)
AF071218   .b 29 to 2078 487 to 2533 exact     2533/2534
(99 %)
3 diff
(99.9 %id)
AF095193   .b 29 to 2078 487 to 2533 Q109K Q119R     2533/2534
(99 %)
6 diff
(99.8 %id)
AF127139   .b 29 to 2109 459 to 2536 C33R AAA   2536/2536
(100 %)
5 diff
(99.9 %id)
AJ710787 heart .a 1602 to 1996 1 to 394       394/394
(100 %)
12 diff
(97.0 %id)
AJ711861 heart .a 1702 to 2106 1 to 405   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 405/405
(100 %)
2 diff
(99.6 %id)
AK222800 Liver .b 29 to 1600 478 to 2049 C33R Q35R     2049/2049
(100 %)
5 diff
(99.8 %id)
AK291333 tongue .b 29 to 1758 245 to 1974 exact     1974/1974
(100 %)
0 diff
(100 %id)
AK313026 amygdala .a 29 to 1573 432 to 1976 exact     1976/1976
(100 %)
1 diff
(100.0 %id)
AL137582 testis .a 29 to 1791 307 to 2069 exact tiling clone, available from DKFZ, AAA   2069/2069
(100 %)
0 diff
(100 %id)
DA025291   .b 29 to 130 400 to 501   capped   500/500
(100 %)
2 diff
(99.6 %id)
AW390216 stomach .a 1319 to 1836 8 to 527       520/527
(98 %)
6 diff
(98.9 %id)
AW815510 stomach .a 1591 to 1929 11 to 350       340/363
(93 %)
7 diff
(98.1 %id)
AW815636 stomach .a 1611 to 1929 20 to 339       320/352
(90 %)
7 diff
(98.1 %id)
AW953283   .c-u 752 to 1303 1 to 552       552/557
(99 %)
4 diff
(99.3 %id)
BC006418 Placenta, choriocarcinoma .b 29 to 2109 465 to 2545 exact tiling clone, available from MGC, AAA   2545/2545
(100 %)
0 diff
(100 %id)
BC014656 Lung, large cell carcinoma .b 29 to 2109 192 to 2269 exact available from MGC, AAA   2269/2269
(100 %)
2 diff
(100.0 %id)
BC107786 Brain, glioblastoma .b 29 to 2109 291 to 2368 exact AAA   2368/2368
(100 %)
5 diff
(99.8 %id)
BE001973 breast_normal .c-u 419 to 959 1 to 534       534/544
(98 %)
36 diff
(93.4 %id)
BE149808 head_neck .b 484 to 831 376 to 29     Submitted on the opposite strand 348/391
(89 %)
0 diff
(100 %id)
BF805539 colon_ins .e-u 1 to 423 1 to 423   tiling clone,   423/423
(100 %)
2 diff
(99.6 %id)
BF927229 nervous_tumor .c-u 1059 to 1350 1 to 293       293/293
(100 %)
8 diff
(97.3 %id)
DA038128   .b 29 to 158 436 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
BI060479 uterus_tumor .c-u 993 to 1377 19 to 403   tiling clone,   385/403
(95 %)
6 diff
(98.6 %id)
BI481492 Native Retinal Pigment Epithelium sheets, retina .a 1485 to 2107 12 to 638       627/638
(98 %)
5 diff
(99.3 %id)
AV755373 bone marrow .c-u 736 to 1207 69 to 532       464/534
(86 %)
6 diff
(98.9 %id)
AV758567 bone marrow .a 1618 to 2013 93 to 484       392/403
(97 %)
7 diff
(98.3 %id)
DA058609 cerebellum .b 29 to 92 475 to 538   capped   537/538
(99 %)
2 diff
(99.7 %id)
DA062169 cerebellum .b 29 to 123 477 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA075314 cerebellum .b 29 to 226 361 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DA153643 amygdala .b 29 to 56 475 to 502   capped   501/501
(100 %)
0 diff
(100 %id)
DA168953 amygdala .b 29 to 56 475 to 502   capped   501/501
(100 %)
0 diff
(100 %id)
DA202765 brain .b 29 to 132 475 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA266218 caudate nucleus .b 29 to 97 475 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DA266815 caudate nucleus .b 29 to 114 475 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA268222 caudate nucleus .b 29 to 127 475 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA300641 hippocampus .b 29 to 122 475 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA392620 thalamus .b 29 to 128 475 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA394367 thalamus .b 29 to 147 477 to 595   capped   594/594
(100 %)
1 diff
(99.9 %id)
DA395020 thalamus .b 29 to 139 475 to 585   capped   584/584
(100 %)
1 diff
(99.9 %id)
C04061 heart .c-u 859 to 1249 2 to 393       392/393
(99 %)
6 diff
(98.5 %id)
CA407489 adipose .e-u 209 to 663 1 to 455 exact tiling clone,   455/455
(100 %)
1 diff
(99.8 %id)
CB268681 adipose .c-u 1 to 513 1 to 513   tiling clone,   513/517
(99 %)
4 diff
(99.3 %id)
CD618259   .a 1500 to 1921 12 to 430       419/432
(96 %)
6 diff
(98.7 %id)
CD618262   .c-u 441 to 862 1 to 423       423/424
(99 %)
9 diff
(97.9 %id)
CD618264   .b 596 to 1257 1 to 658       658/659
(99 %)
9 diff
(98.7 %id)
CD618265   .a 652 to 1371 1 to 716       716/716
(100 %)
7 diff
(99.1 %id)
CD618267   .a 652 to 1139 1 to 487       487/490
(99 %)
5 diff
(99.0 %id)
CD618270   .c-u 539 to 1086 24 to 579       556/579
(96 %)
6 diff
(99.0 %id)
AU279585   .b 29 to 274 289 to 534       534/534
(100 %)
1 diff
(99.9 %id)
CN355177 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 29 to 298 410 to 679       679/679
(100 %)
0 diff
(100 %id)
CN355178 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 29 to 188 475 to 634       626/634
(98 %)
6 diff
(99.1 %id)
CN355179 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 29 to 210 440 to 621       609/621
(98 %)
7 diff
(98.9 %id)
CN355181 embryonic stem cells, cell lines H1, H7, andH9 .b 29 to 224 482 to 677       655/677
(96 %)
7 diff
(99.0 %id)
CN355182 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 628 to 934 1 to 307       307/307
(100 %)
0 diff
(100 %id)
CN355183 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1320 to 1938 1 to 616       616/616
(100 %)
1 diff
(99.9 %id)
CN355184 embryonic stem cells, cell lines H1, H7, andH9 .b 147 to 580 13 to 447       435/447
(97 %)
6 diff
(98.7 %id)
CN355185 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 113 to 667 1 to 554       554/554
(100 %)
4 diff
(99.3 %id)
BP222989   .b 29 to 469 159 to 599       599/599
(100 %)
0 diff
(100 %id)
BX351116 Neuroblastoma Cot 25-normalized .a 1498 to 2098 601 to 1       601/789
(76 %)
38 diff
(95.2 %id)
BX354639 Neuroblastoma Cot 25-normalized .c-u 461 to 1169 1168 to 473   AAA   696/1143
(60 %)
60 diff
(94.8 %id)
BX355175 Neuroblastoma Cot 50-normalized .b 29 to 335 464 to 768       768/768
(100 %)
5 diff
(99.4 %id)
AL533734 brain, fetal brain .b 1054 to 2098 1040 to 1       1040/1050
(99 %)
19 diff
(98.2 %id)
AL533735 brain, fetal brain .b 29 to 695 382 to 1042       1042/1078
(96 %)
19 diff
(98.3 %id)
BX334784 Placenta Cot 25-normalized .a 1787 to 2025 272 to 34       875/999
(87 %)
5 diff
(99.5 %id)
AL547351 placenta, Placenta Cot 25-normalized .b 29 to 710 309 to 988       959/988
(97 %)
10 diff
(99.0 %id)
AL572315 placenta, Placenta Cot 25-normalized .b 1071 to 2075 1004 to 1       1004/1004
(100 %)
20 diff
(98.1 %id)
AL570514 placenta, Placenta Cot 25-normalized .b 1051 to 2041 999 to 18       982/999
(98 %)
0 diff
(100 %id)
AL545328 placenta, Placenta Cot 25-normalized .b 29 to 402 444 to 817       797/817
(97 %)
22 diff
(97.4 %id)
AL571096 placenta, Placenta Cot 25-normalized .b 1254 to 2052 806 to 1       806/806
(100 %)
9 diff
(98.9 %id)
AL551217 placenta, Placenta Cot 25-normalized .b 29 to 574 466 to 998       998/1037
(96 %)
19 diff
(98.2 %id)
AL574859 placenta, Placenta Cot 25-normalized .b 950 to 2050 1098 to 1       1098/1098
(100 %)
12 diff
(99.0 %id)
AL549056 placenta, Placenta Cot 25-normalized .b 29 to 417 466 to 851       851/851
(100 %)
3 diff
(99.7 %id)
AL573396 placenta, Placenta Cot 25-normalized .b 1191 to 2083 896 to 1       896/896
(100 %)
3 diff
(99.7 %id)
AL548800 placenta, Placenta Cot 25-normalized .b 29 to 389 457 to 813       813/813
(100 %)
5 diff
(99.4 %id)
AL573222 placenta, Placenta Cot 25-normalized .a 1216 to 2079 865 to 1       865/865
(100 %)
3 diff
(99.7 %id)
BX386149 Placenta Cot 25-normalized .a 981 to 2079 1090 to 1       1090/1127
(96 %)
20 diff
(98.3 %id)
BX386150 Placenta Cot 25-normalized .b 29 to 594 457 to 1014       1014/1087
(93 %)
23 diff
(97.9 %id)
BX365058 Placenta Cot 25-normalized .b 1027 to 1875 1113 to 270   AAA   844/1145
(73 %)
0 diff
(100 %id)
BX365059 Placenta Cot 25-normalized .b 29 to 556 454 to 973       973/1046
(93 %)
22 diff
(97.9 %id)
BX383397   .b 1129 to 2054 935 to 13       923/935
(98 %)
0 diff
(100 %id)
BX383398   .b 29 to 472 457 to 896       896/896
(100 %)
5 diff
(99.5 %id)
DA435959 tongue, tumor tissue .b 29 to 56 478 to 505   capped   504/504
(100 %)
1 diff
(99.9 %id)
DA441258 tongue, tumor tissue .b 29 to 129 477 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA448228 tongue, tumor tissue .b 29 to 103 477 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA450175 tongue, tumor tissue .b 29 to 119 475 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA454649 tongue, tumor tissue .b 29 to 194 359 to 524   capped   523/523
(100 %)
0 diff
(100 %id)
CU446535 epidermis .b 220 to 854 15 to 648       634/650
(97 %)
13 diff
(98.0 %id)
CU447069 epidermis .b 227 to 519 18 to 309       292/332
(87 %)
13 diff
(96.1 %id)
CU455929 epidermis .b 220 to 764 15 to 558       544/575
(94 %)
6 diff
(99.0 %id)
CU456957 epidermis .b 29 to 193 188 to 24     Submitted on the opposite strand 255/288
(88 %)
1 diff
(99.7 %id)
CV026961 mixed .b 29 to 498 181 to 650       650/650
(100 %)
1 diff
(99.9 %id)
CV395369 lung_normal .d 1 to 133 22 to 152   tiling clone,   131/152
(86 %)
6 diff
(96.1 %id)
D83876   .b 829 to 1263 1 to 436       436/442
(98 %)
3 diff
(99.4 %id)
DA473654   .b 29 to 303 284 to 558   capped   557/557
(100 %)
4 diff
(99.3 %id)
DA476260   .b 29 to 207 294 to 472   capped   471/471
(100 %)
0 diff
(100 %id)
DA477969   .b 29 to 186 417 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
BX488848   .b 555 to 1161 1 to 607       607/607
(100 %)
3 diff
(99.6 %id)
EC572488 Prostate .b 1850 to 1945 1 to 95       95/95
(100 %)
3 diff
(96.9 %id)
EL594996 epidermis, skin .f-u 1 to 414 16 to 429 exact tiling clone,   414/449
(92 %)
4 diff
(99.2 %id)
EL595022 epidermis, skin .f-u 1 to 397 18 to 414 G20X W52X K55N P56L G57A ... tiling clone,   397/414
(95 %)
6 diff
(98.6 %id)
EL954113 eyeball .c-u 604 to 1080 1 to 477       477/477
(100 %)
8 diff
(98.4 %id)
DA481873   .b 29 to 123 475 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
ES315514 occipital scalp hair, skin .b 593 to 832 1 to 238       238/238
(100 %)
3 diff
(98.8 %id)
T19207   .b 414 to 707 1 to 292       292/292
(100 %)
5 diff
(98.3 %id)
FN062807 breast carcinoma .b 1980 to 2086 1 to 109       109/109
(100 %)
4 diff
(96.4 %id)
CD675232 eye, lens .b 29 to 395 266 to 630       630/630
(100 %)
1 diff
(99.9 %id)
CD676236 eye, lens .b 29 to 329 250 to 550       550/559
(98 %)
1 diff
(99.9 %id)
DA550547   .b 132 to 537 2 to 408   capped   407/408
(99 %)
7 diff
(98.3 %id)
BP238569 Liver .b 29 to 164 478 to 613       613/616
(99 %)
16 diff
(97.5 %id)
DA574878   .b 29 to 107 477 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA576805   .b 29 to 308 288 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA578546   .b 29 to 117 477 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA582633 lung .b 29 to 273 294 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
DA602707   .b 29 to 307 286 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
CN484409 eye .b 29 to 221 416 to 608       608/608
(100 %)
0 diff
(100 %id)
H10349 whole brain .a 1679 to 2076 406 to 1   fully sequenced,   406/406
(100 %)
12 diff
(97.1 %id)
H10530 whole brain .a 1180 to 1709 1 to 541   fully sequenced,   541/541
(100 %)
20 diff
(96.4 %id)
H10621 whole brain .c-u 736 to 1106 1 to 372       372/373
(99 %)
4 diff
(99.0 %id)
T83345 liver and spleen .b 1787 to 2107 336 to 7       330/413
(79 %)
0 diff
(100 %id)
T83492 liver and spleen .b 795 to 1124 1 to 336       336/343
(97 %)
10 diff
(97.1 %id)
N52974 liver and spleen .a 1633 to 2106 472 to 1       472/473
(99 %)
4 diff
(99.2 %id)
N50541 multiple sclerosis lesions .b 1651 to 2114 465 to 1       465/465
(100 %)
6 diff
(98.8 %id)
N50595 multiple sclerosis lesions .b 770 to 1242 1 to 480       480/480
(100 %)
8 diff
(98.4 %id)
N54028 multiple sclerosis lesions .c-u 1020 to 1239 1 to 220       220/220
(100 %)
1 diff
(99.6 %id)
W39035 parathyroid gland, parathyroid tumor .a 1592 to 1919 1 to 328       328/353
(92 %)
1 diff
(99.8 %id)
N98564 senescent fibroblast .a 1650 to 2106 485 to 13   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 473/473
(100 %)
25 diff
(94.8 %id)
W24247 senescent fibroblast .a 923 to 1235 15 to 333     Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 319/333
(95 %)
6 diff
(98.2 %id)
W15235 parathyroid gland, parathyroid tumor .a 1729 to 2110 385 to 3       383/388
(98 %)
0 diff
(100 %id)
W39165 parathyroid gland, parathyroid tumor .a 1183 to 1594 1 to 419       419/445
(94 %)
15 diff
(96.7 %id)
W61030 senescent fibroblast .a 1597 to 2106 15 to 524       510/524
(97 %)
6 diff
(98.9 %id)
W58065 heart .c-u 638 to 949 1 to 321       321/335
(95 %)
14 diff
(95.9 %id)
W58398.
matches multiple genes
heart .a 1602 to 2106 516 to 12   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base), also hits gene losarbo 505/508
(99 %)
12 diff
(97.7 %id)
AA034925.
matches multiple genes
uterus .b 1874 to 2109 236 to 1     also hits gene CSPP1 236/236
(100 %)
0 diff
(100 %id)
AA034933 uterus .a 1758 to 1977 1 to 217       217/222
(97 %)
2 diff
(99.1 %id)
AA040866 uterus .a 1639 to 2106 474 to 1   fully sequenced,   474/474
(100 %)
20 diff
(95.8 %id)
AA043135 uterus .a 1112 to 1661 1 to 552   fully sequenced,   552/552
(100 %)
7 diff
(98.8 %id)
AA121931 uterus .a 1800 to 2101 308 to 1   fully sequenced,   308/308
(100 %)
3 diff
(99.1 %id)
AA121949 uterus .a 1561 to 1830 1 to 275   fully sequenced,   275/275
(100 %)
3 diff
(99.0 %id)
AA101635 uterus .a 1758 to 2106 1 to 346   fully sequenced,   346/346
(100 %)
1 diff
(99.8 %id)
AA101636 uterus .a 1771 to 2106 334 to 1   fully sequenced,   334/334
(100 %)
1 diff
(99.8 %id)
AA134754 uterus .b 177 to 496 1 to 325       325/328
(99 %)
17 diff
(94.9 %id)
AA150669 uterus .a 1807 to 2108 299 to 1   fully sequenced,   299/299
(100 %)
4 diff
(98.7 %id)
AA150793 uterus .a 1520 to 1837 1 to 324   fully sequenced,   324/324
(100 %)
10 diff
(97.0 %id)
AA176341 muscle, skeletal muscle .a 1636 to 2082 445 to 1       445/445
(100 %)
2 diff
(99.6 %id)
AA187312   .a 1605 to 2107 507 to 3       505/513
(98 %)
0 diff
(100 %id)
AA187413   .a 808 to 1237 1 to 429       429/431
(99 %)
16 diff
(96.3 %id)
AA432265.
matches multiple genes
  .c-u 904 to 1286 395 to 13   AAA also hits gene BUB1BandPAK6 383/383
(100 %)
0 diff
(100 %id)
AA431253   .c-u 869 to 1280 1 to 411       411/411
(100 %)
1 diff
(99.8 %id)
AA633832 lung .b 1959 to 2108 150 to 1       150/150
(100 %)
0 diff
(100 %id)
AA570012 breast .a 1687 to 2107 419 to 1       419/419
(100 %)
2 diff
(99.6 %id)
AA588774 colon, colon tumor .a 1646 to 2106 461 to 1       461/461
(100 %)
0 diff
(100 %id)
AA669911 bone marrow stroma .a 1780 to 2106 323 to 1       323/323
(100 %)
4 diff
(98.8 %id)
AA669917 bone marrow stroma .b 1797 to 2113 313 to 1       313/313
(100 %)
2 diff
(99.4 %id)
AA631159 colon, colon tumor RER+ .b 1791 to 2108 318 to 1       318/318
(100 %)
1 diff
(99.7 %id)
AA858033 Kidney .a 1744 to 2064 377 to 57   AAA   321/363
(88 %)
0 diff
(100 %id)
AA838837 parathyroid gland, parathyroid tumor .a 1634 to 2110 480 to 4       477/480
(99 %)
0 diff
(100 %id)
AA825435 carcinoid, lung .a 1662 to 2074 408 to 1       408/408
(100 %)
4 diff
(99.1 %id)
AA878033 colon, colon tumor .a 1754 to 2105 351 to 1       351/351
(100 %)
1 diff
(99.8 %id)
AA856641 adenocarcinoma, colon .b 1804 to 2110 305 to 3       303/305
(99 %)
0 diff
(100 %id)
AA865662 2 pooled tumors (clear cell type), Kidney .b 1842 to 2112 271 to 1       271/271
(100 %)
0 diff
(100 %id)
AA916616 adenocarcinoma, colon .b 1760 to 2110 352 to 3       350/352
(99 %)
0 diff
(100 %id)
AA919051 Kidney .a 1748 to 2106 356 to 1       356/356
(100 %)
1 diff
(99.8 %id)
AA954169 Kidney, kidney tumor .a 1592 to 2061 465 to 1       465/465
(100 %)
2 diff
(99.6 %id)
AI168492 breast .a 1662 to 2106 441 to 1       441/442
(99 %)
2 diff
(99.6 %id)
AI031842 parathyroid gland, parathyroid tumor .a 1628 to 2110 485 to 3       483/485
(99 %)
0 diff
(100 %id)
AI031602 parathyroid gland, parathyroid tumor .a 1704 to 2110 409 to 3       407/409
(99 %)
0 diff
(100 %id)
AI026041 parathyroid gland, parathyroid tumor .a 1668 to 2110 442 to 4       439/442
(99 %)
0 diff
(100 %id)
AI031987 parathyroid gland, parathyroid tumor .a 1703 to 2110 407 to 3       405/407
(99 %)
0 diff
(100 %id)
AI128908 senescent fibroblast .a 1719 to 2106 396 to 11   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 386/386
(100 %)
7 diff
(98.2 %id)
AI074490 brain, glioblastoma (pooled) .a 1658 to 2107 446 to 1       446/446
(100 %)
2 diff
(99.6 %id)
AI078496 liver and spleen .a 1703 to 2110 408 to 1       408/408
(100 %)
0 diff
(100 %id)
AI092248 heart .b 1809 to 2111 299 to 1       299/299
(100 %)
3 diff
(99.0 %id)
AI161227 brain, glioblastoma (pooled) .a 1641 to 2106 462 to 1       462/462
(100 %)
2 diff
(99.6 %id)
AI160359 uterus .a 1768 to 2106 336 to 1       336/336
(100 %)
6 diff
(98.3 %id)
AI189197 placenta .a 1633 to 2107 475 to 1       475/477
(99 %)
3 diff
(99.4 %id)
AI262785 Kidney .a 1637 to 2106 466 to 1       466/466
(100 %)
4 diff
(99.2 %id)
AI261757 Kidney .a 1632 to 2103 477 to 6       472/477
(98 %)
0 diff
(100 %id)
AI269958 Kidney .a 1711 to 2106 396 to 1       396/396
(100 %)
31 diff
(92.2 %id)
AI262309 adenocarcinoma, colon .a 1720 to 2110 388 to 1       388/388
(100 %)
3 diff
(99.3 %id)
AI350287 carcinoid, lung .a 1710 to 2106 395 to 1       395/395
(100 %)
2 diff
(99.5 %id)
AI350309 carcinoid, lung .a 1718 to 2110 395 to 6       390/395
(98 %)
0 diff
(100 %id)
AI264758 adenocarcinoma, Pancreas .b 1804 to 2109 304 to 1       304/304
(100 %)
4 diff
(98.7 %id)
AI373934 uterus .a 1613 to 2072 457 to 1       457/457
(100 %)
1 diff
(99.8 %id)
AI371684 brain, glioblastoma (pooled) .a 1628 to 2106 476 to 1       476/476
(100 %)
2 diff
(99.6 %id)
AI381521 pooled .a 1628 to 2110 483 to 4       480/483
(99 %)
0 diff
(100 %id)
AI471024 brain, glioblastoma (pooled) .b 1900 to 2109 211 to 1       211/211
(100 %)
1 diff
(99.6 %id)
AI380810 B-cell, chronic lymphotic leukemia .a 1716 to 2105 390 to 1       390/390
(100 %)
0 diff
(100 %id)
AI478422 Kidney .a 1733 to 2110 378 to 4       375/378
(99 %)
0 diff
(100 %id)
AI601139 colon .a 1710 to 2106 397 to 1       397/397
(100 %)
0 diff
(100 %id)
AI918312 anaplastic oligodendroglioma, brain .a 1808 to 2113 309 to 3       307/310
(99 %)
0 diff
(100 %id)
AI587080 adenocarcinoma, Pancreas .a 1604 to 2103 502 to 3       500/502
(99 %)
0 diff
(100 %id)
AI685767 Prostate .c-u 1049 to 1290 247 to 6       242/247
(97 %)
0 diff
(100 %id)
AI685768 Prostate .c-u 1049 to 1288 240 to 1       240/240
(100 %)
1 diff
(99.6 %id)
AI919346 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 1863 to 2109 244 to 1       244/244
(100 %)
4 diff
(98.4 %id)
AI611357 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 1861 to 2109 247 to 1       247/247
(100 %)
1 diff
(99.6 %id)
AI690618 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 1766 to 2110 348 to 4       345/348
(99 %)
0 diff
(100 %id)
AI826479 normal prostate, Prostate .a 1553 to 2106 550 to 1       550/550
(100 %)
3 diff
(99.5 %id)
AI826921 normal prostate, Prostate .a 1762 to 2106 342 to 1       342/342
(100 %)
7 diff
(98.0 %id)
AI949349 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c-u 862 to 1290 429 to 1       429/429
(100 %)
2 diff
(99.6 %id)
AI991954 anaplastic oligodendroglioma, brain .a 1626 to 2110 481 to 1       481/488
(98 %)
3 diff
(99.4 %id)
AW003885 brain, glioblastoma (pooled) .a 1572 to 2106 532 to 1       532/532
(100 %)
1 diff
(99.9 %id)
AI983779 colon, colonic mucosa from 3 patients with Crohn'sdisease .a 1650 to 2110 460 to 3       458/460
(99 %)
0 diff
(100 %id)
AW028190 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 1685 to 2075 387 to 1       387/387
(100 %)
2 diff
(99.5 %id)
AW192113 adenocarcinoma, Pancreas .a 1710 to 2075 366 to 1       366/366
(100 %)
2 diff
(99.5 %id)
AW197933 adenocarcinoma, Pancreas .b 1939 to 2110 173 to 2       172/173
(99 %)
0 diff
(100 %id)
AW515445 Kidney, renal cell tumor .a 1547 to 2110 560 to 3       558/601
(92 %)
0 diff
(100 %id)
AW515201 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 1773 to 2106 334 to 1       334/334
(100 %)
2 diff
(99.5 %id)
AW316606 brain, three pooled meningiomas .a 1667 to 2075 406 to 1       406/406
(100 %)
2 diff
(99.6 %id)
AW337358 adenocarcinoma, Pancreas .a 1759 to 2102 344 to 1       344/344
(100 %)
1 diff
(99.8 %id)
AW778906 colon, moderately-differentiated adenocarcinoma .a 1655 to 2101 444 to 1       444/444
(100 %)
2 diff
(99.6 %id)
BQ028393 mixed .a 1600 to 2106 522 to 19   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 504/504
(100 %)
1 diff
(99.9 %id)
AW873162 adrenal gland, neuroblastoma .a 1628 to 2108 479 to 1       479/479
(100 %)
2 diff
(99.6 %id)
BE281360 choriocarcinoma, placenta .b 29 to 352 253 to 585       585/609
(96 %)
28 diff
(95.5 %id)
CB050049 Prostate .a 1720 to 2059 12 to 348       337/348
(96 %)
13 diff
(96.3 %id)
BF591533 brain, glioblastoma (pooled) .a 1578 to 2106 526 to 1       526/526
(100 %)
1 diff
(99.9 %id)
BF001366 Prostate .b 1802 to 2109 305 to 1       305/305
(100 %)
4 diff
(98.7 %id)
BE543029 cervical carcinoma cell line, cervix .c-u 457 to 1235 1 to 775       775/787
(98 %)
26 diff
(96.7 %id)
BF593187 Kidney .a 1673 to 2107 435 to 1       435/435
(100 %)
0 diff
(100 %id)
BE391977 endometrium, adenocarcinoma cell line, uterus .b 29 to 76 499 to 546       505/546
(92 %)
17 diff
(96.9 %id)
BE391525 endometrium, adenocarcinoma cell line, uterus .b 29 to 96 443 to 510       510/513
(99 %)
2 diff
(99.7 %id)
BE386774 melanotic melanoma, skin .b 29 to 405 499 to 879       843/953
(88 %)
24 diff
(97.5 %id)
BE409341 choriocarcinoma, placenta .b 29 to 300 445 to 710       710/736
(96 %)
10 diff
(98.7 %id)
BE735565 adenocarcinoma, Pancreas .b 29 to 692 101 to 770       770/946
(81 %)
18 diff
(98.1 %id)
BE735534 adenocarcinoma, Pancreas .a 259 to 1016 1 to 752       752/1002
(75 %)
22 diff
(97.9 %id)
BE737407 adenocarcinoma, Pancreas .c-u 518 to 1314 78 to 887       810/977
(82 %)
6 diff
(99.4 %id)
BF030018 hypernephroma, Kidney .a 1626 to 2105 1 to 473   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 473/473
(100 %)
12 diff
(97.5 %id)
BE737566 brain, glioblastoma .b 1799 to 2109 1 to 305   AAA   305/305
(100 %)
7 diff
(97.8 %id)
BF033562 adenocarcinoma, ovary .b 333 to 951 1 to 630       630/860
(73 %)
33 diff
(96.2 %id)
BE621156 epithelioid carcinoma, Pancreas .a 1097 to 1529 1 to 434   fully sequenced,   434/434
(100 %)
1 diff
(99.8 %id)
BE965816 epithelioid carcinoma, Pancreas .a 1491 to 2087 601 to 3   fully sequenced,   599/601
(99 %)
0 diff
(100 %id)
BE905286 epithelioid carcinoma, Pancreas .b 29 to 488 251 to 709       709/710
(99 %)
8 diff
(98.9 %id)
BE886341 leiomyosarcoma, uterus .b 766 to 1469 1 to 706       706/837
(84 %)
8 diff
(99.1 %id)
BE896533 melanotic melanoma, skin .b 29 to 484 247 to 707       705/1324
(53 %)
42 diff
(96.9 %id)
BE902305 choriocarcinoma, placenta .b 22 to 365 258 to 623       604/1149
(52 %)
69 diff
(94.0 %id)
BF314994 brain, neuroblastoma .c-u 506 to 1011 1 to 510       510/892
(57 %)
17 diff
(98.1 %id)
BG030583 breast, mammary adenocarcinoma, cell line .c-u 551 to 1138 1 to 591       591/752
(78 %)
7 diff
(99.1 %id)
BG120015 adenocarcinoma, cell line, Liver .d 108 to 716 1 to 611 L39H P40S G41R R42E A43G ... tiling clone,   611/611
(100 %)
6 diff
(99.1 %id)
BG250975 adenocarcinoma, cell line, Liver .b 771 to 1483 1 to 717       717/720
(99 %)
10 diff
(98.7 %id)
BG286659 bladder, transitional cell papilloma, cell line .b 617 to 1389 1 to 770       770/1017
(75 %)
19 diff
(98.2 %id)
BG282695 adenocarcinoma, cell line, Prostate .b 618 to 1330 1 to 730       730/1016
(71 %)
22 diff
(97.9 %id)
BG332799 large cell carcinoma, lung .b 29 to 619 272 to 854       852/854
(99 %)
20 diff
(97.7 %id)
BG420258 Kidney, renal cell adenocarcinoma .b 29 to 409 285 to 668       668/1084
(61 %)
37 diff
(96.6 %id)
BG548654 lung .b 558 to 1219 1 to 669       669/669
(100 %)
15 diff
(97.8 %id)
BG528716 adenocarcinoma, Prostate .a 1501 to 2106 1 to 602   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 602/602
(100 %)
7 diff
(98.9 %id)
BG612083 adenocarcinoma, Prostate .c-u 404 to 1108 1 to 714       714/714
(100 %)
13 diff
(98.2 %id)
BG763628 melanotic melanoma, high MDR (cell line), skin .b 29 to 502 362 to 838       838/842
(99 %)
16 diff
(98.1 %id)
BG769028 melanotic melanoma, high MDR (cell line), skin .b 29 to 422 361 to 753       753/753
(100 %)
3 diff
(99.7 %id)
BG770258 melanotic melanoma, high MDR (cell line), skin .b 29 to 556 361 to 884       884/918
(96 %)
21 diff
(97.8 %id)
BI198651 brain, neuroblastoma .c-u 513 to 1064 1 to 561       561/987
(56 %)
32 diff
(96.8 %id)
BG831689 epithelioid carcinoma cell line, Pancreas .b 29 to 475 143 to 588       588/588
(100 %)
5 diff
(99.2 %id)
BI160309 epithelioid carcinoma cell line, Pancreas .b 29 to 355 410 to 731       731/1218
(60 %)
40 diff
(96.8 %id)
BI194701 epithelioid carcinoma cell line, Pancreas .b 29 to 356 263 to 598       598/973
(61 %)
27 diff
(97.3 %id)
BI822296 pooled brain, lung, testis .b 29 to 223 283 to 477       477/477
(100 %)
0 diff
(100 %id)
BI760377 pooled colon, kidney, stomach .b 29 to 223 268 to 463       463/463
(100 %)
2 diff
(99.6 %id)
BI759835 pooled colon, kidney, stomach .b 29 to 223 305 to 499       499/499
(100 %)
2 diff
(99.6 %id)
BI761648 pooled colon, kidney, stomach .a 418 to 1259 1 to 850       850/850
(100 %)
18 diff
(97.9 %id)
BI764859 pooled colon, kidney, stomach .b 29 to 223 455 to 651       651/651
(100 %)
13 diff
(98.1 %id)
BI763030 pooled colon, kidney, stomach .a 1702 to 2106 1 to 405   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 405/405
(100 %)
2 diff
(99.6 %id)
BI764443 pooled colon, kidney, stomach .c-u 304 to 728 1 to 429       429/507
(84 %)
9 diff
(98.3 %id)
BI523980 pooled lung and spleen .b 108 to 223 1 to 116       116/116
(100 %)
0 diff
(100 %id)
BI524527 pooled lung and spleen .b 1335 to 2031 709 to 1       709/1013
(69 %)
23 diff
(97.8 %id)
BI518668 leukocyte .b 29 to 223 267 to 461       461/461
(100 %)
0 diff
(100 %id)
BI519751 leukocyte .a 1249 to 2034 812 to 1       812/812
(100 %)
40 diff
(95.1 %id)
BI911287 leukocyte .b 29 to 339 299 to 631       610/975
(62 %)
41 diff
(95.8 %id)
BI907396 leukocyte .b 29 to 223 299 to 492       466/492
(94 %)
7 diff
(98.6 %id)
BI908845 leukocyte .b 29 to 222 376 to 570       536/571
(93 %)
9 diff
(98.5 %id)
BI910853 leukocyte .b 29 to 223 274 to 468       468/468
(100 %)
3 diff
(99.4 %id)
BI914210 brain .b 29 to 223 465 to 659       659/659
(100 %)
2 diff
(99.7 %id)
BI855993 breast, mammary adenocarcinoma, cell line .c-u 867 to 1333 1 to 478       478/479
(99 %)
9 diff
(98.2 %id)
BM051165 eye, normal pigmented retinal epithelium .a 145 to 863 1 to 743       743/804
(92 %)
28 diff
(96.6 %id)
BM556717 amelanotic melanoma, cell line, skin .c-u 308 to 1278 28 to 1010 H3F S258A S259A M260*     983/1011
(97 %)
23 diff
(97.8 %id)
BM449674 melanotic melanoma, skin .b 271 to 1098 12 to 846       835/887
(94 %)
18 diff
(98.0 %id)
BM800951 melanotic melanoma, skin .a 134 to 1089 1 to 967       967/1045
(92 %)
27 diff
(97.5 %id)
BM557325 melanotic melanoma, skin .b 29 to 753 298 to 1039       1039/1071
(97 %)
46 diff
(95.8 %id)
BM550204 melanotic melanoma, skin .a 1297 to 2106 1 to 810   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 810/810
(100 %)
5 diff
(99.4 %id)
BQ073133 leukocyte .b 29 to 649 284 to 920       907/1107
(81 %)
38 diff
(96.6 %id)
BQ278930 adenocarcinoma, cell line, breast .b 29 to 261 457 to 697       697/1127
(61 %)
19 diff
(98.4 %id)
BQ010060 Chondrosarcoma, Left Pubic Bone .a 1632 to 2106 493 to 19   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 475/475
(100 %)
3 diff
(99.4 %id)
BQ008515 Chondrosarcoma, Left Pubic Bone .a 1372 to 2106 753 to 19   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 735/736
(99 %)
1 diff
(99.9 %id)
BQ017083 lung, Metastatic Chondrosarcoma .a 1484 to 2106 638 to 19   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 620/620
(100 %)
2 diff
(99.7 %id)
BQ222126 epithelioid carcinoma, Pancreas .c-u 499 to 1351 1 to 864       864/904
(95 %)
39 diff
(95.7 %id)
BQ233212 epithelioid carcinoma, Pancreas .b 447 to 1202 1 to 766       766/922
(83 %)
19 diff
(98.0 %id)
BQ421980 melanotic melanoma, skin .b 29 to 271 301 to 548       528/1109
(47 %)
36 diff
(96.8 %id)
BU181679 epithelioid carcinoma, Pancreas .a 277 to 1152 1 to 879       879/888
(98 %)
15 diff
(98.4 %id)
BU948575 Pancreas, Purified pancreatic islet .c-u 910 to 1348 439 to 1   fully sequenced,   439/439
(100 %)
0 diff
(100 %id)
BU948817 Pancreas, Purified pancreatic islet .c-u 392 to 940 1 to 549   tiling clone, fully sequenced,   549/549
(100 %)
0 diff
(100 %id)
BQ427693 leiomyosarcoma, uterus .b 29 to 512 376 to 867       867/867
(100 %)
13 diff
(98.6 %id)
BQ718716 sympathetic trunk .b 29 to 353 273 to 602       602/1037
(58 %)
10 diff
(99.1 %id)
BQ716055 sympathetic trunk .b 29 to 469 345 to 804       727/1069
(68 %)
38 diff
(96.5 %id)
BQ721119 sympathetic trunk .b 29 to 606 274 to 863       863/935
(92 %)
21 diff
(97.8 %id)
BQ722180 sympathetic trunk .b 226 to 1085 1 to 865       865/912
(94 %)
14 diff
(98.5 %id)
BQ690667 ductal carcinoma, cell line, Pancreas .b 29 to 605 261 to 845       845/851
(99 %)
12 diff
(98.6 %id)
BQ707279 Spleen .b 29 to 88 476 to 536       512/1091
(46 %)
16 diff
(98.6 %id)
BU509596 leiomyosarcoma, uterus .b 29 to 353 386 to 710       710/839
(84 %)
3 diff
(99.7 %id)
CA843018 Pancreas, Purified pancreatic islet .b 816 to 1438 11 to 633       623/633
(98 %)
6 diff
(99.1 %id)
CA843776 Pancreas, Purified pancreatic islet .c-u 898 to 1348 451 to 1   tiling clone,   451/451
(100 %)
0 diff
(100 %id)
BU539777 adenocarcinoma, cell line, breast .b 29 to 156 537 to 672       593/1195
(49 %)
29 diff
(97.6 %id)
BU858005 adenocarcinoma, cell line, breast .a 1004 to 1888 38 to 936       899/937
(95 %)
6 diff
(99.4 %id)
BU929064 brain, glioblastoma .b 29 to 558 290 to 836       836/886
(94 %)
31 diff
(96.6 %id)
CX166234 human embryonic stem cells differentiated toan early endodermal cell type .b 29 to 638 162 to 771       771/771
(100 %)
0 diff
(100 %id)
CX782421 human embryonic stem cells .b 1465 to 2109 671 to 30   fully sequenced, AAA   642/642
(100 %)
3 diff
(99.6 %id)
CX782506 human embryonic stem cells .b 773 to 1495 1 to 723   fully sequenced,   723/723
(100 %)
1 diff
(99.9 %id)
CX784524 human embryonic stem cells .c-u 430 to 1248 1 to 819       819/819
(100 %)
1 diff
(99.9 %id)
CB997025 placenta, pre-eclamptic placenta .b 29 to 213 502 to 690       671/799
(83 %)
17 diff
(97.9 %id)
CD106043 brain, Pituitary .b 721 to 1538 1 to 824       824/828
(99 %)
15 diff
(98.2 %id)
CD243870 testis .b 29 to 533 225 to 745       745/872
(85 %)
27 diff
(97.0 %id)
CD250678 Blood vessels - aorta, basilar and artery .a 1475 to 2096 1 to 626       626/773
(80 %)
10 diff
(98.8 %id)
CD557530 testis .b 29 to 446 396 to 820       818/886
(92 %)
20 diff
(97.8 %id)
CF264996 Brain glioblastoma .b 29 to 302 447 to 729       729/940
(77 %)
20 diff
(97.9 %id)
CF243159 Brain glioblastoma .b 29 to 423 447 to 844       844/844
(100 %)
15 diff
(98.3 %id)
CF995303 Pooled Chondrosarcoma Tumor cells .a 1503 to 2085 100 to 689       590/1035
(57 %)
32 diff
(97.0 %id)
CF121362 CNCAP(3)T-225 cell line, Prostate .c-u 490 to 1172 1 to 683       683/683
(100 %)
7 diff
(99.0 %id)
CF994215 Human Placenta, placenta .b 29 to 308 500 to 788       773/830
(93 %)
21 diff
(97.5 %id)
CK001271 brain/CNS, Bulk tissue from Human Spinal cord .c-u 477 to 1164 1 to 687       687/687
(100 %)
6 diff
(99.2 %id)
TI_57199127   .b 29 to 454 314 to 739       708/739
(95 %)
6 diff
(99.2 %id)
TI_57148148   .b 29 to 604 301 to 887       824/887
(92 %)
42 diff
(95.3 %id)
TI_57148601   .b 29 to 587 361 to 921       863/943
(91 %)
28 diff
(97.1 %id)
TI_57149067   .a 418 to 1259 37 to 886       850/886
(95 %)
23 diff
(97.5 %id)
TI_57149712   .b 29 to 352 455 to 782       782/802
(97 %)
20 diff
(97.6 %id)
TI_57150256   .a 1698 to 2106 52 to 460   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 409/460
(88 %)
6 diff
(98.7 %id)
TI_57152548   .c-u 307 to 728 68 to 493       426/571
(74 %)
7 diff
(98.8 %id)
TI_44159739   .b 108 to 1007 30 to 924       895/925
(96 %)
23 diff
(97.6 %id)
TI_44159740   .b 1335 to 2031 709 to 1       709/1013
(69 %)
23 diff
(97.8 %id)
TI_44459825   .b 29 to 563 328 to 865       802/903
(88 %)
10 diff
(98.9 %id)
TI_44459827   .a 1249 to 2034 812 to 1       812/812
(100 %)
40 diff
(95.1 %id)
TI_57231429   .b 29 to 339 299 to 631       610/975
(62 %)
41 diff
(95.8 %id)
TI_57232597   .b 29 to 391 299 to 660       634/660
(96 %)
7 diff
(99.0 %id)
TI_57234690   .b 29 to 336 376 to 688       654/688
(95 %)
16 diff
(97.7 %id)
TI_57236526   .b 29 to 422 300 to 693       673/694
(96 %)
9 diff
(98.8 %id)
TI_57242841   .b 29 to 466 495 to 933       903/958
(94 %)
25 diff
(97.4 %id)
TI_57186469   .c-u 865 to 1333 52 to 531       480/481
(99 %)
9 diff
(98.2 %id)
N56380   .c-u 1110 to 1298 1 to 184       184/187
(98 %)
7 diff
(96.3 %id)
BP279044   .b 29 to 355 285 to 610       610/617
(98 %)
4 diff
(99.4 %id)
BP279067   .b 29 to 352 285 to 608       608/608
(100 %)
1 diff
(99.9 %id)
BP279205   .b 187 to 761 1 to 574       574/577
(99 %)
9 diff
(98.5 %id)
CB148428 Liver .a 1465 to 1928 1 to 461       461/461
(100 %)
1 diff
(99.8 %id)
CB159909 Liver .a 1327 to 1860 1 to 531       531/531
(100 %)
2 diff
(99.7 %id)
DA652820   .b 29 to 122 475 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA654590   .b 29 to 114 477 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA655085   .b 29 to 319 293 to 583   capped   582/582
(100 %)
7 diff
(98.8 %id)
DA655473   .b 29 to 148 436 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DA661256   .b 29 to 114 473 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA664547   .b 29 to 202 475 to 651   capped   650/658
(98 %)
6 diff
(99.1 %id)
DB322082   .b 1687 to 2109 423 to 1       423/423
(100 %)
7 diff
(98.4 %id)
BG939014 Bone, Hip .c-u 585 to 1244 1 to 660       660/660
(100 %)
6 diff
(99.1 %id)
NM_004281.3   .b 29 to 2109 487 to 2567 exact RefSeq, AAA   2567/2567
(100 %)
0 diff
(100 %id)
DA711862   .b 29 to 180 417 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DB363802   .b 1550 to 2109 561 to 1       561/561
(100 %)
18 diff
(96.8 %id)
DB366937   .b 1476 to 2078 594 to 1       594/595
(99 %)
21 diff
(96.5 %id)
DA736103   .b 29 to 320 477 to 770   capped   769/773
(99 %)
14 diff
(98.2 %id)
DB368531   .b 1575 to 2109 534 to 1       534/544
(98 %)
16 diff
(97.1 %id)
DA736469   .b 29 to 75 475 to 521   capped   520/529
(98 %)
5 diff
(99.1 %id)
DB368950   .b 1560 to 2109 540 to 1       540/543
(99 %)
23 diff
(95.8 %id)
DA742871   .b 29 to 71 475 to 517   capped   516/516
(100 %)
0 diff
(100 %id)
DA747340   .b 29 to 71 510 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
DA765187 tongue .b 29 to 347 245 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
BP316548 pericardium .a 1457 to 2041 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
DA826925 pericardium .b 29 to 308 289 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DA867493 Prostate .b 1 to 536 2 to 537   tiling clone, capped   536/536
(100 %)
2 diff
(99.7 %id)
DA880716   .b 29 to 326 184 to 483   capped   482/482
(100 %)
15 diff
(96.9 %id)
DA880731   .b 29 to 225 196 to 392   capped   391/398
(98 %)
4 diff
(99.0 %id)
DA880863   .b 29 to 411 165 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA881134   .b 29 to 160 444 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DA882037   .b 29 to 102 477 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA883350   .b 29 to 419 157 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA883385   .b 29 to 118 475 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA883524   .b 29 to 213 285 to 469   capped   468/468
(100 %)
0 diff
(100 %id)
DA883723   .b 29 to 394 197 to 562   capped   561/561
(100 %)
3 diff
(99.5 %id)
DA884850   .b 29 to 419 165 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
DA884914   .b 29 to 392 189 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA886569   .b 29 to 336 245 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA886856   .b 29 to 122 476 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA889260   .b 29 to 293 285 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA890032   .b 29 to 156 436 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA891709 rectum .b 29 to 180 398 to 549   capped   548/548
(100 %)
4 diff
(99.3 %id)
CR994415 T-Lymphocytes .a 122 to 996 1 to 871       871/874
(99 %)
6 diff
(99.4 %id)
CR979856 T-Lymphocytes .b 536 to 1404 1 to 873       873/875
(99 %)
6 diff
(99.4 %id)
BM835118 stomach .b 29 to 328 218 to 517       517/517
(100 %)
0 diff
(100 %id)
BM784583 lymph node, stomach .b 29 to 71 366 to 408       408/408
(100 %)
1 diff
(99.8 %id)
F30598 pectoral muscle (after mastectomy) .a 1749 to 2030 1 to 280       280/280
(100 %)
3 diff
(99.0 %id)
TI_1948138382   .b 29 to 477 304 to 755       640/1391
(46 %)
14 diff
(99.0 %id)
TI_1948138383   .b 29 to 923 304 to 1186   AAA   1071/1388
(77 %)
51 diff
(96.4 %id)
TI_1948138384   .b 756 to 1578 951 to 126       826/1137
(72 %)
0 diff
(100 %id)
TI_1948138385   .c-u 460 to 1131 803 to 130       674/1350
(49 %)
0 diff
(100 %id)
TI_1948138990   .b 29 to 480 306 to 765       648/1410
(45 %)
30 diff
(97.9 %id)
TI_1948138991   .b 29 to 687 308 to 979       860/1561
(55 %)
25 diff
(98.4 %id)
TI_1948138992   .c-u 386 to 1131 884 to 122       763/1378
(55 %)
0 diff
(100 %id)
TI_1948138993   .c-u 420 to 1131 840 to 129       712/1404
(50 %)
0 diff
(100 %id)
TI_1948139297   .b 29 to 357 310 to 643       522/1469
(35 %)
42 diff
(97.2 %id)
TI_1948139298   .b 1039 to 1578 667 to 123       545/1293
(42 %)
0 diff
(100 %id)
DA894224 skeletal muscle .c-u 397 to 962 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DA913558   .b 29 to 133 476 to 580   capped   579/579
(100 %)
2 diff
(99.7 %id)
BP352386   .a 378 to 970 1 to 593       593/593
(100 %)
4 diff
(99.4 %id)
T30424 colon, endothelial .c-u 977 to 1249 1 to 273       273/273
(100 %)
1 diff
(99.7 %id)
T30773 adipose .b 439 to 683 1 to 246       246/246
(100 %)
3 diff
(98.8 %id)
T33545 brain .c-u 737 to 1132 1 to 397       397/397
(100 %)
2 diff
(99.5 %id)
DN995595 breast cancer, Mammary gland (cancer tissue) .b 29 to 197 386 to 554       546/554
(98 %)
6 diff
(99.0 %id)
DB018897 esophageal, tumor tissue .b 29 to 316 285 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DB139230 thymus .b 29 to 232 315 to 518   capped   517/517
(100 %)
1 diff
(99.9 %id)
TI_149299972   .a 1437 to 2106 752 to 85   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 668/668
(100 %)
2 diff
(99.8 %id)
TI_154108456   .a 1306 to 2106 881 to 95   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 787/902
(87 %)
13 diff
(98.6 %id)
TI_154180402   .c-u 497 to 1346 71 to 914       844/848
(99 %)
14 diff
(98.4 %id)
DB190068 lung, tumor tissue .b 29 to 123 477 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DB198807 trachea .b 29 to 312 285 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DB204945 trachea .b 29 to 114 476 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DB205316 trachea .b 29 to 304 285 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DB242559 stomach, tumor tissue .b 29 to 305 290 to 565   capped   564/564
(100 %)
4 diff
(99.3 %id)
BM976137 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 1458 to 2106 665 to 19   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 647/647
(100 %)
2 diff
(99.7 %id)
BU607641 Human Lung Epithelial cells, lung .b 1896 to 2078 201 to 19   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 183/261
(70 %)
1 diff
(99.7 %id)
CA944410 Human Lung Epithelial cells, lung .b 1896 to 2078 201 to 19   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 183/261
(70 %)
1 diff
(99.7 %id)
CA312314 Human Lung Epithelial cells, lung .b 1879 to 2078 218 to 19   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 200/223
(89 %)
0 diff
(100 %id)
BM686047 eye, Retina Foveal and Macular .a 1216 to 1718 11 to 512   fully sequenced, Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 502/512
(98 %)
6 diff
(98.9 %id)
BU726081 eye, Retina Foveal and Macular .a 1688 to 2106 433 to 18   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 416/416
(100 %)
7 diff
(98.4 %id)
BM686987 eye, optic nerve .a 1150 to 1550 2 to 402   fully sequenced, Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 401/402
(99 %)
5 diff
(98.8 %id)
BU727464 eye, optic nerve .a 1520 to 2106 605 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 587/587
(100 %)
0 diff
(100 %id)
BM716292 eye, optic nerve .a 1200 to 1502 1 to 303   fully sequenced, Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 303/303
(100 %)
0 diff
(100 %id)
BU733542 eye, optic nerve .a 1472 to 2106 653 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 635/635
(100 %)
0 diff
(100 %id)
BU737923 eye, lens .a 1703 to 2106 421 to 19   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 403/403
(100 %)
4 diff
(99.1 %id)
BM675383 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1545 to 2106 580 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 562/562
(100 %)
0 diff
(100 %id)
BM714870 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 989 to 1575 1 to 587   fully sequenced, Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 587/587
(100 %)
1 diff
(99.9 %id)
CA447583 Chondrosarcoma, Left Pelvis .a 1372 to 2106 749 to 19   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 731/731
(100 %)
4 diff
(99.5 %id)
BU632757 cell lines, Chondrosarcoma .a 1391 to 2106 732 to 19   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 714/714
(100 %)
3 diff
(99.6 %id)
CA426385 cell lines, Chondrosarcoma .a 1353 to 2106 769 to 19   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 751/752
(99 %)
4 diff
(99.5 %id)
BU621949 Cell Line, Chondrosarcoma .a 1370 to 2106 754 to 19   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 736/736
(100 %)
2 diff
(99.8 %id)
BU622940 cell lines, Chondrosarcoma .a 1328 to 2106 794 to 19   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 776/776
(100 %)
2 diff
(99.8 %id)
CA307110 Alveolar Macrophage, lung .a 1370 to 2106 751 to 19   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 733/733
(100 %)
3 diff
(99.6 %id)
CA309333 Alveolar Macrophage, lung .a 1412 to 2106 707 to 19   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 689/716
(96 %)
5 diff
(99.4 %id)
TI_151770263   .c-u 756 to 1375 110 to 725       616/1053
(58 %)
14 diff
(98.7 %id)
TI_151774421   .a 1258 to 2074 100 to 911   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 812/812
(100 %)
11 diff
(98.7 %id)
DB265734 uterus .b 29 to 126 475 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DB267402 uterus .b 29 to 177 415 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
DA019179   .b 29 to 213 502 to 690   capped   671/799
(83 %)
17 diff
(97.9 %id)
DA031085   .b 721 to 1538 1 to 824   capped   824/828
(99 %)
15 diff
(98.2 %id)
DA085201 cerebellum .b 721 to 1538 1 to 824   capped   824/828
(99 %)
15 diff
(98.2 %id)
DA085718 cerebellum .b 29 to 533 225 to 745   capped Suspected internal deletion, this clone was ignored 745/872
(85 %)
27 diff
(97.0 %id)
DA148102 amygdala .a 1475 to 2096 1 to 626   capped   626/773
(80 %)
10 diff
(98.8 %id)
DA151736 amygdala .b 29 to 446 396 to 820   capped   818/886
(92 %)
20 diff
(97.8 %id)
DA159317 amygdala .b 29 to 302 447 to 729   capped   729/940
(77 %)
20 diff
(97.9 %id)
DA174312 amygdala .b 29 to 423 447 to 844   capped Suspected internal deletion, this clone was ignored 844/844
(100 %)
15 diff
(98.3 %id)
DA181110 amygdala .a 1503 to 2085 100 to 689   capped   590/1035
(57 %)
32 diff
(97.0 %id)
DA296630 hippocampus .c-u 490 to 1172 1 to 683   capped   683/683
(100 %)
7 diff
(99.0 %id)
DA296984 hippocampus .c-u 490 to 1172 1 to 683   capped Suspected internal deletion, this clone was ignored 683/683
(100 %)
7 diff
(99.0 %id)
DA310430 hippocampus .b 29 to 308 500 to 788   capped   773/830
(93 %)
21 diff
(97.5 %id)
CN355180 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 29 to 308 500 to 788     Suspected internal deletion, this clone was ignored 773/830
(93 %)
21 diff
(97.5 %id)
DA434295 tongue, tumor tissue .c-u 477 to 1164 1 to 687   capped   687/687
(100 %)
6 diff
(99.2 %id)
DA436944 tongue, tumor tissue .c-u 477 to 1164 1 to 687   capped   687/687
(100 %)
6 diff
(99.2 %id)
DA440331 tongue, tumor tissue .b 29 to 454 314 to 739   capped   708/739
(95 %)
6 diff
(99.2 %id)
DA440539 tongue, tumor tissue .b 29 to 604 301 to 887   capped   824/887
(92 %)
42 diff
(95.3 %id)
DA443379 tongue, tumor tissue .b 29 to 587 361 to 921   capped   863/943
(91 %)
28 diff
(97.1 %id)
DA444106 tongue, tumor tissue .a 418 to 1259 37 to 886   capped   850/886
(95 %)
23 diff
(97.5 %id)
ES312236 frontal balding hair, skin .b 29 to 352 455 to 782       782/802
(97 %)
20 diff
(97.6 %id)
DA544295   .a 1698 to 2106 52 to 460   capped   409/460
(88 %)
6 diff
(98.7 %id)
DA568647 whole embryo, mainly head .c-u 307 to 728 68 to 493   capped Suspected internal deletion, this clone was ignored 426/571
(74 %)
7 diff
(98.8 %id)
DB355183 whole embryo, mainly head .b 108 to 1007 30 to 924     Suspected internal deletion, this clone was ignored 895/925
(96 %)
23 diff
(97.6 %id)
AU098867   .b 1335 to 2031 709 to 1       709/1013
(69 %)
23 diff
(97.8 %id)
AU103657   .b 29 to 563 328 to 865       802/903
(88 %)
10 diff
(98.9 %id)
AA282538 germinal center B cell .a 1249 to 2034 812 to 1     Suspected internal deletion, this clone was ignored 812/812
(100 %)
40 diff
(95.1 %id)
AA282643 germinal center B cell .b 29 to 339 299 to 631     Suspected internal deletion, this clone was ignored 610/975
(62 %)
41 diff
(95.8 %id)
AA280315 germinal center B cell .b 29 to 391 299 to 660     Suspected internal deletion, this clone was ignored 634/660
(96 %)
7 diff
(99.0 %id)
AA280559 germinal center B cell .b 29 to 336 376 to 688     Suspected internal deletion, this clone was ignored 654/688
(95 %)
16 diff
(97.7 %id)
AI492211 B-cell, chronic lymphotic leukemia .b 29 to 422 300 to 693     Suspected internal deletion, this clone was ignored 673/694
(96 %)
9 diff
(98.8 %id)
AI766969 2 pooled tumors (clear cell type), Kidney .b 29 to 466 495 to 933     Suspected internal deletion, this clone was ignored 903/958
(94 %)
25 diff
(97.4 %id)
BG749990 eye, normal pigmented retinal epithelium .c-u 865 to 1333 52 to 531     Suspected internal deletion, this clone was ignored 480/481
(99 %)
9 diff
(98.2 %id)
BI462741 testis .c-u 1110 to 1298 1 to 184       184/187
(98 %)
7 diff
(96.3 %id)
DA621834 Kidney .b 29 to 355 285 to 610   capped Suspected internal deletion, this clone was ignored 610/617
(98 %)
4 diff
(99.4 %id)
DA716752   .b 29 to 352 285 to 608   capped   608/608
(100 %)
1 diff
(99.9 %id)
DA719422   .b 187 to 761 1 to 574   capped   574/577
(99 %)
9 diff
(98.5 %id)
DA761014 tongue .a 1465 to 1928 1 to 461   capped   461/461
(100 %)
1 diff
(99.8 %id)
DA766782 tongue .a 1327 to 1860 1 to 531   capped   531/531
(100 %)
2 diff
(99.7 %id)
DA892485 rectum .b 29 to 122 475 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA983756 synovial membrane tissue from rheumatioidarthritis .b 29 to 114 477 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
TI_149311813   .b 29 to 319 293 to 583   AAA Suspected internal deletion, this clone was ignored 582/582
(100 %)
7 diff
(98.8 %id)
BM977572 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 29 to 148 436 to 555   AAA Suspected internal deletion, this clone was ignored 554/554
(100 %)
1 diff
(99.9 %id)
DA661256   .b 29 to 114 473 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA664547   .b 29 to 202 475 to 651   capped   650/658
(98 %)
6 diff
(99.1 %id)
DB322082   .b 1687 to 2109 423 to 1       423/423
(100 %)
7 diff
(98.4 %id)
BG939014 Bone, Hip .c-u 585 to 1244 1 to 660       660/660
(100 %)
6 diff
(99.1 %id)
BG939014 Bone, Hip .c-u 585 to 1244 1 to 660       660/660
(100 %)
6 diff
(99.1 %id)
NM_004281.3   .b 29 to 2109 487 to 2567 exact RefSeq, AAA   2567/2567
(100 %)
0 diff
(100 %id)
DA711862   .b 29 to 180 417 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DB363802   .b 1550 to 2109 561 to 1       561/561
(100 %)
18 diff
(96.8 %id)
DB366937   .b 1476 to 2078 594 to 1       594/595
(99 %)
21 diff
(96.5 %id)
DA736103   .b 29 to 320 477 to 770   capped   769/773
(99 %)
14 diff
(98.2 %id)
DB368531   .b 1575 to 2109 534 to 1       534/544
(98 %)
16 diff
(97.1 %id)
DA736469   .b 29 to 75 475 to 521   capped   520/529
(98 %)
5 diff
(99.1 %id)
DB368950   .b 1560 to 2109 540 to 1       540/543
(99 %)
23 diff
(95.8 %id)
DA742871   .b 29 to 71 475 to 517   capped   516/516
(100 %)
0 diff
(100 %id)
DA747340   .b 29 to 71 510 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
DA765187 tongue .b 29 to 347 245 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
BP316548 pericardium .a 1457 to 2041 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
DA826925 pericardium .b 29 to 308 289 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DA867493 Prostate .b 1 to 536 2 to 537   tiling clone, capped   536/536
(100 %)
2 diff
(99.7 %id)
DA880716   .b 29 to 326 184 to 483   capped   482/482
(100 %)
15 diff
(96.9 %id)
DA880731   .b 29 to 225 196 to 392   capped   391/398
(98 %)
4 diff
(99.0 %id)
DA880863   .b 29 to 411 165 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA881134   .b 29 to 160 444 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DA882037   .b 29 to 102 477 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA883350   .b 29 to 419 157 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA883385   .b 29 to 118 475 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA883524   .b 29 to 213 285 to 469   capped   468/468
(100 %)
0 diff
(100 %id)
DA883723   .b 29 to 394 197 to 562   capped   561/561
(100 %)
3 diff
(99.5 %id)
DA884850   .b 29 to 419 165 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
DA884914   .b 29 to 392 189 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA886569   .b 29 to 336 245 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA886856   .b 29 to 122 476 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA889260   .b 29 to 293 285 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA890032   .b 29 to 156 436 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA891709 rectum .b 29 to 180 398 to 549   capped   548/548
(100 %)
4 diff
(99.3 %id)
CR994415 T-Lymphocytes .a 122 to 996 1 to 871       871/874
(99 %)
6 diff
(99.4 %id)
CR979856 T-Lymphocytes .b 536 to 1404 1 to 873       873/875
(99 %)
6 diff
(99.4 %id)
BM835118 stomach .b 29 to 328 218 to 517       517/517
(100 %)
0 diff
(100 %id)
BM784583 lymph node, stomach .b 29 to 71 366 to 408       408/408
(100 %)
1 diff
(99.8 %id)
BM784583 lymph node, stomach .b 29 to 71 366 to 408       408/408
(100 %)
1 diff
(99.8 %id)
F30598 pectoral muscle (after mastectomy) .a 1749 to 2030 1 to 280       280/280
(100 %)
3 diff
(99.0 %id)
TI_1948138382   .b 29 to 477 304 to 755       640/1391
(46 %)
14 diff
(99.0 %id)
TI_1948138383   .b 29 to 923 304 to 1186   AAA   1071/1388
(77 %)
51 diff
(96.4 %id)
TI_1948138384   .b 756 to 1578 951 to 126       826/1137
(72 %)
0 diff
(100 %id)
TI_1948138385   .c-u 460 to 1131 803 to 130       674/1350
(49 %)
0 diff
(100 %id)
TI_1948138990   .b 29 to 480 306 to 765       648/1410
(45 %)
30 diff
(97.9 %id)
TI_1948138991   .b 29 to 687 308 to 979       860/1561
(55 %)
25 diff
(98.4 %id)
TI_1948138992   .c-u 386 to 1131 884 to 122       763/1378
(55 %)
0 diff
(100 %id)
TI_1948138993   .c-u 420 to 1131 840 to 129       712/1404
(50 %)
0 diff
(100 %id)
TI_1948139297   .b 29 to 357 310 to 643       522/1469
(35 %)
42 diff
(97.2 %id)
TI_1948139298   .b 1039 to 1578 667 to 123       545/1293
(42 %)
0 diff
(100 %id)
DA894224 skeletal muscle .c-u 397 to 962 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DA913558   .b 29 to 133 476 to 580   capped   579/579
(100 %)
2 diff
(99.7 %id)
BP352386   .a 378 to 970 1 to 593       593/593
(100 %)
4 diff
(99.4 %id)
T30424 colon, endothelial .c-u 977 to 1249 1 to 273       273/273
(100 %)
1 diff
(99.7 %id)
T30424 colon, endothelial .c-u 977 to 1249 1 to 273       273/273
(100 %)
1 diff
(99.7 %id)
T30773 adipose .b 439 to 683 1 to 246       246/246
(100 %)
3 diff
(98.8 %id)
T33545 brain .c-u 737 to 1132 1 to 397       397/397
(100 %)
2 diff
(99.5 %id)
DN995595 breast cancer, Mammary gland (cancer tissue) .b 29 to 197 386 to 554       546/554
(98 %)
6 diff
(99.0 %id)
DN995595 breast cancer, Mammary gland (cancer tissue) .b 29 to 197 386 to 554       546/554
(98 %)
6 diff
(99.0 %id)
DB018897 esophageal, tumor tissue .b 29 to 316 285 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DB139230 thymus .b 29 to 232 315 to 518   capped   517/517
(100 %)
1 diff
(99.9 %id)
TI_149299972   .a 1437 to 2106 752 to 85   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 668/668
(100 %)
2 diff
(99.8 %id)
TI_154108456   .a 1306 to 2106 881 to 95   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 787/902
(87 %)
13 diff
(98.6 %id)
TI_154180402   .c-u 497 to 1346 71 to 914       844/848
(99 %)
14 diff
(98.4 %id)
DB190068 lung, tumor tissue .b 29 to 123 477 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DB198807 trachea .b 29 to 312 285 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DB204945 trachea .b 29 to 114 476 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DB205316 trachea .b 29 to 304 285 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DB242559 stomach, tumor tissue .b 29 to 305 290 to 565   capped   564/564
(100 %)
4 diff
(99.3 %id)
BM976137 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 1458 to 2106 665 to 19   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 647/647
(100 %)
2 diff
(99.7 %id)
BM976137 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 1458 to 2106 665 to 19   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 647/647
(100 %)
2 diff
(99.7 %id)
BU607641 Human Lung Epithelial cells, lung .b 1896 to 2078 201 to 19   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 183/261
(70 %)
1 diff
(99.7 %id)
BU607641 Human Lung Epithelial cells, lung .b 1896 to 2078 201 to 19   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 183/261
(70 %)
1 diff
(99.7 %id)
CA944410 Human Lung Epithelial cells, lung .b 1896 to 2078 201 to 19   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 183/261
(70 %)
1 diff
(99.7 %id)
CA944410 Human Lung Epithelial cells, lung .b 1896 to 2078 201 to 19   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 183/261
(70 %)
1 diff
(99.7 %id)
CA312314 Human Lung Epithelial cells, lung .b 1879 to 2078 218 to 19   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 200/223
(89 %)
0 diff
(100 %id)
CA312314 Human Lung Epithelial cells, lung .b 1879 to 2078 218 to 19   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 200/223
(89 %)
0 diff
(100 %id)
BM686047 eye, Retina Foveal and Macular .a 1216 to 1718 11 to 512   fully sequenced, Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 502/512
(98 %)
6 diff
(98.9 %id)
BM686047 eye, Retina Foveal and Macular .a 1216 to 1718 11 to 512   fully sequenced, Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 502/512
(98 %)
6 diff
(98.9 %id)
BU726081 eye, Retina Foveal and Macular .a 1688 to 2106 433 to 18   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 416/416
(100 %)
7 diff
(98.4 %id)
BU726081 eye, Retina Foveal and Macular .a 1688 to 2106 433 to 18   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 416/416
(100 %)
7 diff
(98.4 %id)
BM686987 eye, optic nerve .a 1150 to 1550 2 to 402   fully sequenced, Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 401/402
(99 %)
5 diff
(98.8 %id)
BM686987 eye, optic nerve .a 1150 to 1550 2 to 402   fully sequenced, Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 401/402
(99 %)
5 diff
(98.8 %id)
BU727464 eye, optic nerve .a 1520 to 2106 605 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 587/587
(100 %)
0 diff
(100 %id)
BU727464 eye, optic nerve .a 1520 to 2106 605 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 587/587
(100 %)
0 diff
(100 %id)
BM716292 eye, optic nerve .a 1200 to 1502 1 to 303   fully sequenced, Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 303/303
(100 %)
0 diff
(100 %id)
BM716292 eye, optic nerve .a 1200 to 1502 1 to 303   fully sequenced, Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 303/303
(100 %)
0 diff
(100 %id)
BU733542 eye, optic nerve .a 1472 to 2106 653 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 635/635
(100 %)
0 diff
(100 %id)
BU733542 eye, optic nerve .a 1472 to 2106 653 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 635/635
(100 %)
0 diff
(100 %id)
BU737923 eye, lens .a 1703 to 2106 421 to 19   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 403/403
(100 %)
4 diff
(99.1 %id)
BU737923 eye, lens .a 1703 to 2106 421 to 19   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 403/403
(100 %)
4 diff
(99.1 %id)
BM675383 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1545 to 2106 580 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 562/562
(100 %)
0 diff
(100 %id)
BM675383 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1545 to 2106 580 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 562/562
(100 %)
0 diff
(100 %id)
BM714870 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 989 to 1575 1 to 587   fully sequenced, Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 587/587
(100 %)
1 diff
(99.9 %id)
BM714870 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 989 to 1575 1 to 587   fully sequenced, Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 587/587
(100 %)
1 diff
(99.9 %id)
CA447583 Chondrosarcoma, Left Pelvis .a 1372 to 2106 749 to 19   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 731/731
(100 %)
4 diff
(99.5 %id)
CA447583 Chondrosarcoma, Left Pelvis .a 1372 to 2106 749 to 19   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 731/731
(100 %)
4 diff
(99.5 %id)
BU632757 cell lines, Chondrosarcoma .a 1391 to 2106 732 to 19   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 714/714
(100 %)
3 diff
(99.6 %id)
BU632757 cell lines, Chondrosarcoma .a 1391 to 2106 732 to 19   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 714/714
(100 %)
3 diff
(99.6 %id)
CA426385 cell lines, Chondrosarcoma .a 1353 to 2106 769 to 19   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 751/752
(99 %)
4 diff
(99.5 %id)
CA426385 cell lines, Chondrosarcoma .a 1353 to 2106 769 to 19   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 751/752
(99 %)
4 diff
(99.5 %id)
BU621949 Cell Line, Chondrosarcoma .a 1370 to 2106 754 to 19   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 736/736
(100 %)
2 diff
(99.8 %id)
BU621949 Cell Line, Chondrosarcoma .a 1370 to 2106 754 to 19   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 736/736
(100 %)
2 diff
(99.8 %id)
BU622940 cell lines, Chondrosarcoma .a 1328 to 2106 794 to 19   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 776/776
(100 %)
2 diff
(99.8 %id)
BU622940 cell lines, Chondrosarcoma .a 1328 to 2106 794 to 19   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 776/776
(100 %)
2 diff
(99.8 %id)
CA307110 Alveolar Macrophage, lung .a 1370 to 2106 751 to 19   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 733/733
(100 %)
3 diff
(99.6 %id)
CA307110 Alveolar Macrophage, lung .a 1370 to 2106 751 to 19   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 733/733
(100 %)
3 diff
(99.6 %id)
CA309333 Alveolar Macrophage, lung .a 1412 to 2106 707 to 19   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 689/716
(96 %)
5 diff
(99.4 %id)
CA309333 Alveolar Macrophage, lung .a 1412 to 2106 707 to 19   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 689/716
(96 %)
5 diff
(99.4 %id)
TI_151770263   .c-u 756 to 1375 110 to 725       616/1053
(58 %)
14 diff
(98.7 %id)
TI_151774421   .a 1258 to 2074 100 to 911   AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 812/812
(100 %)
11 diff
(98.7 %id)
DB265734 uterus .b 29 to 126 475 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DB267402 uterus .b 29 to 177 415 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
? Gene Summary Gene on genome mRNA:.a, .b, .c-u, .d, .e-u, .f-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI